A citation-based method for searching scientific literature

Aurora Costa, Maria Grazia Daidone, Laura Daprai, Raffaella Villa, Sabrina Cantù, Silvana Pilotti, Luigi Mariani, Alessandro Gronchi, Jeremy D Henson, Roger R Reddel, Nadia Zaffaroni. Cancer Res 2006
Times Cited: 97







List of co-cited articles
1038 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, Janice A Royds, Thomas R Yeager, Robert A Robinson, Stephen B Wharton, David A Jellinek, Susan M Arbuckle, Jinyoung Yoo,[...]. Clin Cancer Res 2005
201
58

Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.
V Hakin-Smith, D A Jellinek, D Levy, T Carroll, M Teo, W R Timperley, M J McKay, R R Reddel, J A Royds. Lancet 2003
205
49

Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
497
47


Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Gary A Ulaner, Hsuan-Ying Huang, Jesse Otero, Zhiquan Zhao, Leah Ben-Porat, Jaya M Satagopan, Richard Gorlick, Paul Meyers, John H Healey, Andrew G Huvos,[...]. Cancer Res 2003
135
44

Multiple mechanisms of telomere maintenance exist in liposarcomas.
Jay E Johnson, Robert J Varkonyi, Jaclyn Schwalm, Ryan Cragle, Andres Klein-Szanto, Arthur Patchefsky, Edna Cukierman, Margaret von Mehren, Dominique Broccoli. Clin Cancer Res 2005
49
75

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
37

Telomere maintenance by recombination in human cells.
M A Dunham, A A Neumann, C L Fasching, R R Reddel. Nat Genet 2000
647
36

A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
34

Telomere elongation in immortal human cells without detectable telomerase activity.
T M Bryan, A Englezou, J Gupta, S Bacchetti, R R Reddel. EMBO J 1995
980
34


Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
282
32

Alternative lengthening of telomeres in mammalian cells.
Jeremy D Henson, Axel A Neumann, Thomas R Yeager, Roger R Reddel. Oncogene 2002
459
30

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
626
30

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
565
29


DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
267
26

Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.
J Arturo Londoño-Vallejo, Héra Der-Sarkissian, Lucien Cazes, Silvia Bacchetti, Roger R Reddel. Cancer Res 2004
213
25

Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
K Perrem, L M Colgin, A A Neumann, T R Yeager, R R Reddel. Mol Cell Biol 2001
193
25

Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.
Raffaella Villa, Maria Grazia Daidone, Rosita Motta, Lorenza Venturini, Cinzia De Marco, Alberto Vannelli, Shigeki Kusamura, Dario Baratti, Marcello Deraco, Aurora Costa,[...]. Clin Cancer Res 2008
49
48

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
344
24

Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Gary A Ulaner, Andrew R Hoffman, Jesse Otero, Hsuan-Ying Huang, Zhiquan Zhao, Madhu Mazumdar, Richard Gorlick, Paul Meyers, John H Healey, Marc Ladanyi. Genes Chromosomes Cancer 2004
69
31

Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically.
Elizabeth Montgomery, Pedram Argani, Jessica L Hicks, Angelo M DeMarzo, Alan K Meeker. Am J Pathol 2004
71
29

Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jennie N Jeyapalan, Aaron Mendez-Bermudez, Nadia Zaffaroni, Yuri E Dubrova, Nicola J Royle. Int J Cancer 2008
40
52

Homologous recombination generates T-loop-sized deletions at human telomeres.
Richard C Wang, Agata Smogorzewska, Titia de Lange. Cell 2004
397
20


Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis.
Lorenza Venturini, Rosita Motta, Alessandro Gronchi, MariaGrazia Daidone, Nadia Zaffaroni. BMC Cancer 2010
27
74

Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
Wei-Qin Jiang, Ze-Huai Zhong, Jeremy D Henson, Axel A Neumann, Andy C-M Chang, Roger R Reddel. Mol Cell Biol 2005
102
19

Telomerase expression predicts unfavorable outcome in osteosarcoma.
Robert P Sanders, Rachid Drissi, Catherine A Billups, Najat C Daw, Marcus B Valentine, Jeffrey S Dome. J Clin Oncol 2004
69
27

Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
18

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
18

Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome.
Jau-Yu Liau, Jia-Huei Tsai, Yung-Ming Jeng, Jen-Chieh Lee, Hung-Han Hsu, Ching-Yao Yang. Am J Surg Pathol 2015
52
34

Mammalian telomeres end in a large duplex loop.
J D Griffith, L Comeau, S Rosenfield, R M Stansel, A Bianchi, H Moss, T de Lange. Cell 1999
16

Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition.
Oliver E Bechter, Ying Zou, William Walker, Woodring E Wright, Jerry W Shay. Cancer Res 2004
152
16


Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Rachel Litman Flynn, Kelli E Cox, Maya Jeitany, Hiroaki Wakimoto, Alysia R Bryll, Neil J Ganem, Francesca Bersani, Jose R Pineda, Mario L Suvà, Cyril H Benes,[...]. Science 2015
246
16


Telomere dynamics in an immortal human cell line.
J P Murnane, L Sabatier, B A Marder, W F Morgan. EMBO J 1994
313
15


Telomere maintenance by telomerase and by recombination can coexist in human cells.
M A Cerone, J A Londono-Vallejo, S Bacchetti. Hum Mol Genet 2001
145
15

Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Toshihiro Matsuo, Jerry W Shay, Woodring E Wright, Eiso Hiyama, Shoji Shimose, Tadahiko Kubo, Takashi Sugita, Yuji Yasunaga, Mitsuo Ochi. J Bone Joint Surg Am 2009
20
75

Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.
Susan M Bailey, Mark A Brenneman, Edwin H Goodwin. Nucleic Acids Res 2004
167
14

Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres.
Ze-Huai Zhong, Wei-Qin Jiang, Anthony J Cesare, Axel A Neumann, Renu Wadhwa, Roger R Reddel. J Biol Chem 2007
104
14

Control of telomere length by a trimming mechanism that involves generation of t-circles.
Hilda A Pickett, Anthony J Cesare, Rebecca L Johnston, Axel A Neumann, Roger R Reddel. EMBO J 2009
138
14

Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival.
Kerrie L McDonald, Julie McDonnell, Alessandra Muntoni, Jeremy D Henson, Monika E Hegi, Andreas von Deimling, Helen R Wheeler, Ray J Cook, Michael T Biggs, Nicholas S Little,[...]. J Neuropathol Exp Neurol 2010
62
22

Distinct factors control histone variant H3.3 localization at specific genomic regions.
Aaron D Goldberg, Laura A Banaszynski, Kyung-Min Noh, Peter W Lewis, Simon J Elsaesser, Sonja Stadler, Scott Dewell, Martin Law, Xingyi Guo, Xuan Li,[...]. Cell 2010
784
14

Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Jau-Yu Liau, Jia-Huei Tsai, Ching-Yao Yang, Jen-Chieh Lee, Cher-Wei Liang, Hung-Han Hsu, Yung-Ming Jeng. Hum Pathol 2015
30
46

The first molecular details of ALT in human tumor cells.
Alessandra Muntoni, Roger R Reddel. Hum Mol Genet 2005
156
13

A novel telomere structure in a human alternative lengthening of telomeres cell line.
Robert A Marciniak, David Cavazos, Richard Montellano, Qijun Chen, Leonard Guarente, F Brad Johnson. Cancer Res 2005
59
22

A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Maria A Cerone, Chantal Autexier, J Arturo Londoño-Vallejo, Silvia Bacchetti. Oncogene 2005
52
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.